Search research articles
Contact Us
Filters
Showing results (191-200 of 274) with videos related to
Page
of 28
Sort By:
Clinical Rheumatology
|
September 14, 2020
The effect of intravenous golimumab on health-related quality of life and work productivity in adult patients with active ankylosing spondylitis: results of the phase 3 GO-ALIVE trial
John D Reveille, Mark C Hwang, Abhijeet Danve, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
October 9, 2020
Effects of Intravenous Golimumab on Health-Related Quality of Life in Patients With Psoriatic Arthritis: 24-Week Results of the GO-VIBRANT Trial
M Elaine Husni, Arthur Kavanaugh, Eric K H Chan, et al.
ACS Nano
|
June 3, 2024
Acidic Nanoparticles Restore Lysosomal Acidification and Rescue Metabolic Dysfunction in Pancreatic β-Cells under Lipotoxic Conditions
Chih Hung Lo, Lance M O'Connor, Gavin Wen Zhao Loi, et al.
Rheumatology and Therapy
|
June 15, 2023
Effect of Intravenous Golimumab on Fatigue and the Relationship with Clinical Response in Adults with Active Ankylosing Spondylitis in the Phase 3 GO-ALIVE Study
Atul Deodhar, Natalie J Shiff, Cinty Gong, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 29, 2024
Peptide-based allosteric inhibitor targets TNFR1 conformationally active region and disables receptor-ligand signaling complex
Jialiu Zeng, Gavin Wen Zhao Loi, Eka Norfaishanty Saipuljumri, et al.
International Journal of Molecular Sciences
|
May 27, 2023
Serum microRNA Levels as a Biomarker for Diagnosing Non-Alcoholic Fatty Liver Disease in Chinese Colorectal Polyp Patients
Lui Ng, Ryan Wai-Yan Sin, David Him Cheung, et al.
Rheumatology (Oxford, England)
|
December 14, 2024
Efficacy and safety of guselkumab in patients with active lupus nephritis: results from a phase 2, randomized, placebo-controlled study
Hans-Joachim Anders, Tak Mao Chan, Jorge Sanchez-Guerrero, et al.
Science Advances
|
November 9, 2018
Correlative 3D x-ray fluorescence and ptychographic tomography of frozen-hydrated green algae
Junjing Deng, Yuan Hung Lo, Marcus Gallagher-Jones, et al.
Annals of the Rheumatic Diseases
|
September 5, 2013
Radiographic benefit and maintenance of clinical benefit with intravenous golimumab therapy in patients with active rheumatoid arthritis despite methotrexate therapy: results up to 1 year of the phase 3, randomised, multicentre, double blind, placebo controlled GO-FURTHER trial
Michael E Weinblatt, Rene Westhovens, Alan M Mendelsohn, et al.
Life Sciences
|
November 1, 2020
Rational design, engineer, and characterization of a novel pegylated single isomer human arginase for arginine depriving anti-cancer treatment
Kuo-Ming Yu, Tammy Pui-Shi Pang, Murray Cutler, et al.
Page
of 28
Search research articles
Search
Showing results (191-200 of 274) with videos related to
Sort By:
Page
of 28
Clinical Rheumatology
|
September 14, 2020
The effect of intravenous golimumab on health-related quality of life and work productivity in adult patients with active ankylosing spondylitis: results of the phase 3 GO-ALIVE trial
John D Reveille, Mark C Hwang, Abhijeet Danve, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
October 9, 2020
Effects of Intravenous Golimumab on Health-Related Quality of Life in Patients With Psoriatic Arthritis: 24-Week Results of the GO-VIBRANT Trial
M Elaine Husni, Arthur Kavanaugh, Eric K H Chan, et al.
ACS Nano
|
June 3, 2024
Acidic Nanoparticles Restore Lysosomal Acidification and Rescue Metabolic Dysfunction in Pancreatic β-Cells under Lipotoxic Conditions
Chih Hung Lo, Lance M O'Connor, Gavin Wen Zhao Loi, et al.
Rheumatology and Therapy
|
June 15, 2023
Effect of Intravenous Golimumab on Fatigue and the Relationship with Clinical Response in Adults with Active Ankylosing Spondylitis in the Phase 3 GO-ALIVE Study
Atul Deodhar, Natalie J Shiff, Cinty Gong, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 29, 2024
Peptide-based allosteric inhibitor targets TNFR1 conformationally active region and disables receptor-ligand signaling complex
Jialiu Zeng, Gavin Wen Zhao Loi, Eka Norfaishanty Saipuljumri, et al.
International Journal of Molecular Sciences
|
May 27, 2023
Serum microRNA Levels as a Biomarker for Diagnosing Non-Alcoholic Fatty Liver Disease in Chinese Colorectal Polyp Patients
Lui Ng, Ryan Wai-Yan Sin, David Him Cheung, et al.
Rheumatology (Oxford, England)
|
December 14, 2024
Efficacy and safety of guselkumab in patients with active lupus nephritis: results from a phase 2, randomized, placebo-controlled study
Hans-Joachim Anders, Tak Mao Chan, Jorge Sanchez-Guerrero, et al.
Science Advances
|
November 9, 2018
Correlative 3D x-ray fluorescence and ptychographic tomography of frozen-hydrated green algae
Junjing Deng, Yuan Hung Lo, Marcus Gallagher-Jones, et al.
Annals of the Rheumatic Diseases
|
September 5, 2013
Radiographic benefit and maintenance of clinical benefit with intravenous golimumab therapy in patients with active rheumatoid arthritis despite methotrexate therapy: results up to 1 year of the phase 3, randomised, multicentre, double blind, placebo controlled GO-FURTHER trial
Michael E Weinblatt, Rene Westhovens, Alan M Mendelsohn, et al.
Life Sciences
|
November 1, 2020
Rational design, engineer, and characterization of a novel pegylated single isomer human arginase for arginine depriving anti-cancer treatment
Kuo-Ming Yu, Tammy Pui-Shi Pang, Murray Cutler, et al.
Page
of 28